Journal of Experimental & Clinical Cancer Research 2008, 27:51 http://www.jeccr.com/content/27/1/51 contribution to acquisition of the clinicopathological and follow-up data. Acknowledgements This work was supported by fund from Department of Science & Technol- ogy of Shandong Province, China (GG3202194). References 1. Kirkali Z, Tuzel E, Mungan MU: Recent advances in kidney cancer and metastatic disease. BJU Int 2001, 88:818-824. 2. Patard JJ, Tazi H, Bensalah K: The changing evolution of renal tumors: a single center experience over a two-decade period. Eur Urol 2004, 45:490-494. 3. Grana X, Reddy FP: Cell cycle control in mammalian cells: role of cyclins, cyclin-dependent kinases (CDK), growth suppres- sor genes and inhibitors (CKIs). Oncogene 1995, 11:211-219. 4. Lloyd RV, Erickson LA, Jin L, Kulig E, Qian X, Cheville JC, Scheithauer BW: p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol 1999, 154:313-323. 5. Porter PL, Malone KE, Heagerty PJ, Alexander GM, Gatti LA, Firpo EJ, Daling JR, Roberts JM: Expression of cell-cycle regulators p27Kip1 and cyclin E, alone or in combination, correlate with survival of young breast patients. Nat Med 1997, 3:222-225. 6. Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, Chau V, Yew PR, Draetta GF, Rolfe M: Role of the ubiquitin-proteas- ome pathway in regulating abundance of the cyclin-depend- ent kinase inhibitor p27. Science 1995, 269:682-5. 7. Spruck C, Strohmaier H, Watson M, Smith AP, Ryan A, Krek TW, Reed SI: A CDK-independent function of mammalian Cks1: targeting of SCF(SKP2) to the CDK inhibitor p27Kip1. Mol Cell 2001, 7:639-50. 8. Masuda TA, Inoue H, Sonoda H, Mine S, Yoshikawa Y, Nakayama T, Nakayama T, Mori M: Clinical and biological significance of S- phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis. Cancer Res 2002, 62:3819-3825. 9. Ganoth D, Bornstein G, Ko TK, Larsen B, Tyers M, Pagano M, Her- shko A: The cell-cycle regulatory protein Cks1 is required for SCF(Skp2)-mediated ubiquitinylation of p27. Nat Cell Biol 2001, 3:321-324. 10. Shapira M, Ben-Izhak O, Linn S, Futerman B, Minkov I, Hershko DD: The prognostic impact of the ubiquitin ligase subunits Skp2 and Cks1 in colorectal carcinoma. Cancer 2005, 103:1336-1346. 11. Slotky M, Shapira M, Ben-Izhak O, Linn S, Futerman B, Tsalic M, Her- shko DD: The expression of the ubiquitin ligase subunit Cks1 in human breast cancer. Breast Cancer Res 2005, 7:R737-744. 12. Yokoi S, Yasui K, Mori M, Iizasa T, Fujisawa T, Inazawa J: Amplifica- tion and overexpression of Skp2 are associated with metas- tasis of non-small-cell lung cancers to lymphnodes. Am J Pathol 2004, 165:175-180. 13. Langner C, vonWasielewski R, Ratschek M, Rehak P, Zigeuner R: Bio- logical significance of p27 and Skp2 expression in renal cell carcinoma. A systematic analysis of primary and metastatic tumour tissues using a tissue microarray technique. Virchows Arch 2004, 445:631-6. 14. Guinan P, Sobin LH, Algaba F, Badellino F, Kameyama S, MacLennan G, Novick A: TNM staging of renal cell carcinoma: Work- group No.3 – Union International Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Can- cer 1997, 80:992-993. 15. Kovacs G, Akhtar M, Beckwith BJ, Bugert P, Cooper CS, Delahunt B, Eble JN, Fleming S, Ljungberg B, Medeiros LJ, Moch H, Reuter VE, Ritz E, Roos G, Schmidt D, Srigley JR, Störkel S, Berg E van den, Zbar B: The Heidelberg classification of renal cell tumors. J Pathol 1997, 183:131-133. 16. Fuhrman SA, Lasky LC, Limas C: Prognostic significance of mor- phologic parameters in renal cell carcinoma. Am J Surg Pathol 1982, 6:655-663. 17. Hershko D, Bornstein G, Ben-Izhak O, Carrano A, Pagano M, Krausz MM, Hershko A: Inverse relation between levels of p27kip1 and of its ubiquitin ligase subunit Skp2 in colorectal carcino- mas. Cancer 2001, 91:1745-1751. 18. Yang RM, Naitoh J, Murphy M, Wang HJ, Phillipson J, deKernion JB, Loda M, Reiter RE: Low p27 expression predicts poor disease- free survival in patients with prostate cancer. J Urol 1998, 159:941-5. 19. Tsihlias J, Kapusta LR, DeBoer G, Morava-Protzner I, Zbieranowski I, Bhattacharya N, Catzavelos GC, Klotz LH, Slingerland JM: Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prog- nostic factor in localized human prostate adenocarcinoma. Cancer Res 1998, 58:542-8. 20. Hedberg Y, Ljungberg B, Roos G, Landberg G: Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarray. Br J Cancer 2003, 88:1417-1423. 21. Migita T, Oda Y, Naito S, Tsuneyoshi M: Low expression of p27kip1 is associated with tumor size and poor prognosis in patients with renal cell carcinoma. Cancer 2002, 94:973-979. 22. Haitel A, Wiener HG, Neudert B, Marberger M, Susani M: Expres- sion of the cell cycle proteins p21, p27, and pRb in clear cell renal cell carcinoma and their prognostic significance. Urol- ogy 2001, 58:477-481. 23. McKay JA, Douglas JJ, Ross VG, Curran S, Ahmed FY, Loane JF, Mur- ray GI, McLeod HL: Expression of cell cycle control proteins in primary colorectal tumors does not always predict expres- sion in lymph node metastases. Clin Cancer Res 2000, 6:1113-1118. 24. Fromont G, Rouprêt M, Amira N, Sibony M, Vallancien G, Validire P, Cussenot O: Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma. Eur Urol 2005, 48:764-70. 25. Huang Hsuan-Ying, Kang Hong-Yo, Li Chien-Feng, Eng Hock-Liew, Chou Shih-Cheng, Lin Ching-Nan, Hsiung Ching-Yeh: Skp2 overex- pression is highly representative of intrinsic biological aggressiveness and independently associated with poor prognosis in primary localized myxofibrosarcomas. Clin Can- cer Res 2006, 12:487-498. 26. Kamura T, Hara T, Matsumoto M, Ishida N, Okumura F, Hatakeyama S, Yoshida M, Nakayama K, Nakayama KI: Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27(Kip1) at G1 phase. Nat Cell Biol 2004, 6:1229-1235. 27. Masuda TA, Inoue H, Nishida K, Sonoda H, Yoshikawa Y, Kakeji Y, Utsunomiya T, Mori M: Cyclin-dependent kinase 1 gene expres- sion is associated with poor prognosis in gastric carcinoma. Clin Cancer Res 2003, 9(15):5693-5698. Publish with Bio Med Central and every scientist can read your work free of charge "BioMed Central will be the most significant development for disseminating the results of biomedical research in our lifetime." Sir Paul Nurse, Cancer Research UK Your research papers will be: available free of charge to the entire biomedical community peer reviewed and published immediately upon acceptance cited in PubMed and archived on PubMed Central yours — you keep the copyright Submit your manuscript here: http://www.biomedcentral.com/info/publishing_adv.asp BioMedcentral Page 8 of 8 (page number not for citation purposes)